Atlas Trials

Open Label Extension Study of HT-100 in Patients With DMD

Clinical trial NCT01978366 · TERMINATED

Trial details

NCT number
NCT01978366
Sponsor
Processa Pharmaceuticals
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Duchenne Muscular Dystrophy
Start date
2013-10-01
Primary completion
2016-04-30
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.